Guyatt G, Rennie D, Meade MO & Cook DJ. Users¡¯ Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice. 3rd ed., New York, USA: McGraw Hill Education & The JAMA Network. 2015.
DiCenzo R, ed. Clinical Pharmacist's Guide to Biostatistics and Literature Evaluation. 2nd ed., Lenexa, KS, USA: American College of Clinical Pharmacy. 2015.
Browner WS, Thomas B Newman TB, Cummings SR. Designing Clinical Research. 5th ed. Wolters Kluwer. 2022.
Malone PM, Witt BA, Malone MJ, Peterson DM. Drug Information: A Guide for Pharmacists, 7th ed. McGraw Hill. 2022.
2)Àü¹®¿µ¿ª °ü·Ã Âü°í¹®Çå
VancomycinTDM
(¹Ì±¹)ASHP/PIDS/SIDP/IDSA revised consensus guideline and review for therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections:
https://www.idsociety.org/practice-guideline/vancomycin/
´ÙÁ¦³»¼º ±×¶÷À½¼º±Õ ¾à¹°¿ä¹ý
(¹Ì±¹) IDSA 2026 guidance on the treatment of antimicrobial resistant Gram-negative infections:
https://www.idsociety.org/practice-guideline/amr-guidance/
(¹Ì±¹) ATS/IDSA guidelines for diagnosis and treatment of adults with community-acquired pneumonia:
https://www.idsociety.org/practice-guideline/community-acquired-pneumonia-cap-in-adults/
(¹Ì±¹) IDSA CAP clinical pathway:
https://www.idsociety.org/globalassets/idsa/practice-guidelines/community-acquired-pneumonia-in-adults/cap-clinical-pathway-final-online.pdf
(¹Ì±¹) ATS/IDSA 2016 clinical practice guidelines for the management of adults with hospital-acquired and ventilator-associated pneumonia:
https://www.idsociety.org/practice-guideline/hap_vap/
ÀÎÇ÷翣ÀÚ
(±¹³») 2025-2026Àý±â ÀÎÇ÷翣ÀÚ °ü¸® Áöħ(PART II. °¢·Ð):
https://www.kdca.go.kr/preview/doc.html?fn=175886999870000&rs=/atchmnfl/preview/result/
(¹Ì±¹) Clinical practice guidelines for the diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza: 2018 update by IDSA:
https://www.idsociety.org/practice-guideline/influenza/
(¹Ì±¹) AHA guidelines on infective endocarditis in adults: Diagnosis, antimicrobial therapy, and management of complications:
https://www.idsociety.org/practice-guideline/endocarditis-management/
(¹Ì±¹) Prevention of infective endocarditis:
https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.106.183095
(¹Ì±¹) Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America:
https://academic.oup.com/cid/article/56/1/e1/415705?login=false
(¹Ì±¹) IDSA 2015 clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults:
https://www.idsociety.org/practice-guideline/vertebral-osteomyelitis/
(¹Ì±¹) IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections:
https://www.idsociety.org/practice-guideline/diabetic-foot-infections/
(¹Ì±¹) Clinical practice guidelines for the management of Clostridioides difficile infection in adults: 2021 update by SHEA/IDSA:
https://www.idsociety.org/practice-guideline/clostridioides-difficile-2021-focused-update/
(¹Ì±¹) Clinical practice guideline for the management of candidiasis: 2016 update by IDSA:
https://www.idsociety.org/practice-guideline/candidiasis/
(¹Ì±¹) Clinical practice guideline for the diagnosis and management of aspergillosis: 2016 update by IDSA:
https://www.idsociety.org/practice-guideline/aspergillosis/
(¹Ì±¹) Strategies to prevent surgical site infections in acute-care hospitals: 2022 update:
https://doi.org/10.1017/ice.2023.67
(¹Ì±¹) Clinical practice guidelines for antimicrobial prophylaxis in surgery:
https://www.ashp.org/surgical-guidelines
»ç¶÷¸é¿ª°áÇ̹ÙÀÌ·¯½º°¨¿° ¹× ±âȸ°¨¿°
(±¹³») HIV °¨¿°ÀÇ Áø´Ü°ú Ä¡·á:
https://icjournal.org/src/sm/ic-53-592-s001.pdf
(±¹³») HIV °¨¿°ÀÎÀÇ ±âȸ°¨¿°Áõ Ä¡·á¿Í ¿¹¹æ:
https://www.icjournal.org/src/sm/ic-48-54-s001.pdf
(±¹³»)±¹³» HIV ³ëÃâ Àü ¿¹¹æ¿ä¹ý ±Ç°í¾È:
https://www.icjournal.org/src/sm/ic-49-243-s001.pdf
(±¹³») HIV °¨¿°ÀÎ Áø·á¸¦ À§ÇÑ ÀÇ·á±â°ü ±æ¶óÀâÀÌ:
https://www.ulsancidc.or.kr/kor/?pCode=MN0000019&pg=4&mode=view&idx=2337
(¹Ì±¹) Primary care guidance for providers who care for persons with human immunodeficiency virus: 2024 update by the HIV Medicine Association of the Infectious Diseases Society of America:
https://www.idsociety.org/practice-guideline/primary-care-management-of-people-with-hiv/
(¹Ì±¹) Guidelines for the use of antiretroviral agents in adults and adolescents with HIV:
https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/whats-new
(¹Ì±¹) Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV:
https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/whats-new
(¹Ì±¹)Recmmendations for the use of antiretroviral drugs during pregnancy and interventions to reduce perinatal HIV transmission in the United States:
https://clinicalinfo.hiv.gov/en/guidelines/perinatal/whats-new
¸é¿ªÀúÇÏ °ü·Ã ±âȸ°¨¿°
(¹Ì±¹) Prevention and Treatment of Cancer-Related Infections, Version 1.2026, NCCN Clinical Practice Guidelines in Oncology:
https://www.nccn.org/professionals/physician_gls/pdf/infections.pdf
(¹Ì±¹) The fourth international consensus guidelines on the management of cytomegalovirus in solid organtransplantation:
https://journals.lww.com/transplantjournal/fulltext/10.1097/tp.0000000000005374~the-fourth-international-consensus-guidelines-on-the
(¹Ì±¹) KDIGO 2009 clinical practice guideline for the care of kidney transplant recipients (chapters 12~14):
https://kdigo.org/guidelines/transplant-recipient/